Henan Taloph Pharmaceutical Stock Co.,Ltd (600222.SS)

CNY 5.13

(0.2%)

EBITDA Summary of Henan Taloph Pharmaceutical Stock Co.,Ltd

  • Henan Taloph Pharmaceutical Stock Co.,Ltd's latest annual EBITDA in 2023 was 111.8 Million CNY , up 77.32% from previous year.
  • Henan Taloph Pharmaceutical Stock Co.,Ltd's latest quarterly EBITDA in 2024 Q3 was 42.65 Million CNY , up 13.73% from previous quarter.
  • Henan Taloph Pharmaceutical Stock Co.,Ltd reported an annual EBITDA of 90.44 Million CNY in 2022, down -51.88% from previous year.
  • Henan Taloph Pharmaceutical Stock Co.,Ltd reported an annual EBITDA of 187.95 Million CNY in 2021, up 16.48% from previous year.
  • Henan Taloph Pharmaceutical Stock Co.,Ltd reported a quarterly EBITDA of 42.65 Million CNY for 2024 Q3, up 13.73% from previous quarter.
  • Henan Taloph Pharmaceutical Stock Co.,Ltd reported a quarterly EBITDA of 27.74 Million CNY for 2024 Q1, down -65.71% from previous quarter.

Annual EBITDA Chart of Henan Taloph Pharmaceutical Stock Co.,Ltd (2023 - 1996)

Historical Annual EBITDA of Henan Taloph Pharmaceutical Stock Co.,Ltd (2023 - 1996)

Year EBITDA EBITDA Growth
2023 111.8 Million CNY 77.32%
2022 90.44 Million CNY -51.88%
2021 187.95 Million CNY 16.48%
2020 142.46 Million CNY -9.85%
2019 98.64 Million CNY 26.59%
2018 141.38 Million CNY 1.67%
2017 67.87 Million CNY 1.76%
2016 63.87 Million CNY 23.75%
2015 43.63 Million CNY -30.75%
2014 108.03 Million CNY 3.56%
2013 108.87 Million CNY 37.7%
2012 77.88 Million CNY 29.77%
2011 57.74 Million CNY 13.85%
2010 61.07 Million CNY 3.78%
2009 70.47 Million CNY 20.11%
2008 58.29 Million CNY 5.94%
2007 54.02 Million CNY 23.93%
2006 43.96 Million CNY 0.29%
2005 46.11 Million CNY 6.75%
2004 43.19 Million CNY 11.89%
2003 38.6 Million CNY 5.3%
2002 36.66 Million CNY -24.73%
2001 48.71 Million CNY -21.69%
2000 59.23 Million CNY 10.83%
1999 56.11 Million CNY -0.95%
1998 56.65 Million CNY -11.34%
1997 63.9 Million CNY 75.82%
1996 36.34 Million CNY 0.0%

Peer EBITDA Comparison of Henan Taloph Pharmaceutical Stock Co.,Ltd

Name EBITDA EBITDA Difference
China Animal Husbandry Industry Co., Ltd. 677.63 Million CNY 83.5%
Guangxi Wuzhou Zhongheng Group Co.,Ltd 348.84 Million CNY 67.949%
Yabao Pharmaceutical Group Co., Ltd 391.76 Million CNY 71.46%
ZhuZhou QianJin Pharmaceutical Co.,Ltd 565.74 Million CNY 80.237%
Tianjin Tianyao Pharmaceuticals Co., Ltd. 479.02 Million CNY 76.659%
Kangmei Pharmaceutical Co., Ltd. 536.71 Million CNY 79.168%
Tasly Pharmaceutical Group Co., Ltd 1.95 Billion CNY 94.28%
Jiangsu Kanion Pharmaceutical Co.,Ltd. 743.16 Million CNY 84.955%
Hubei Jumpcan Pharmaceutical Co., Ltd. 3.61 Billion CNY 96.909%
Shandong Lukang Pharmaceutical Co.,Ltd. 741.88 Million CNY 84.929%
North China Pharmaceutical Company Ltd. 1.51 Billion CNY 92.632%
Zhejiang Shengda Bio-Pharm Co., Ltd. 34.44 Million CNY -224.561%
Zhejiang Starry Pharmaceutical Co.,Ltd. 327.5 Million CNY 65.861%
Heilongjiang ZBD Pharmaceutical Co., Ltd. 840.85 Million CNY 86.703%
Shandong Buchang Pharmaceuticals Co., Ltd. 1.09 Billion CNY 89.801%
Dali Pharmaceuticalco.,Ltd 360.83 Thousand CNY -30886.396%
Guobang Pharma Ltd. 1.04 Billion CNY 89.263%
ChengDu ShengNuo Biotec Co.,Ltd. 121.76 Million CNY 8.173%
Changchun BCHT Biotechnology Co. 662.93 Million CNY 83.134%
Shanghai Haoyuan Chemexpress Co., Ltd. 275.11 Million CNY 59.36%
Zhejiang Huahai Pharmaceutical Co., Ltd. 2.15 Billion CNY 94.813%
Harbin Pharmaceutical Group Co., Ltd. 1.02 Billion CNY 89.085%
Zhejiang Medicine Co., Ltd. 1.13 Billion CNY 90.16%
HPGC Renmintongtai Pharmaceutical Corporation 474.3 Million CNY 76.427%
Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited 971.82 Million CNY 88.495%
Lionco Pharmaceutical Group Co.,Ltd. -90.79 Million CNY 223.15%
Humanwell Healthcare (Group) Co.,Ltd. 4.55 Billion CNY 97.547%
Ginwa Enterprise (Group) Inc. -3.67 Million CNY 3142.208%
KPC Pharmaceuticals, Inc. 801.81 Million CNY 86.056%
Zhejiang Shapuaisi Pharmaceutical Co.,Ltd. 111.25 Million CNY -0.499%
Jiangsu Jibeier Pharmaceutical Co., Ltd. 265.55 Million CNY 57.896%
Ningbo Menovo Pharmaceutical Co., Ltd. 155.45 Million CNY 28.075%
Zhejiang Jiuzhou Pharmaceutical Co., Ltd 1.59 Billion CNY 93.0%
Nanjing Well Pharmaceutical Group Co.,Ltd. 209.72 Million CNY 46.688%
Henan Lingrui Pharmaceutical Co., Ltd. 736.53 Million CNY 84.82%
Joincare Pharmaceutical Group Industry Co.,Ltd. 5.01 Billion CNY 97.77%
China Resources Double-Crane Pharmaceutical Co.,Ltd. 2.21 Billion CNY 94.963%
Chongqing Taiji Industry(Group) Co.,Ltd 1.6 Billion CNY 93.021%
Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited 6.45 Billion CNY 98.269%
China National Medicines Corporation Ltd. 2.82 Billion CNY 96.043%
Shenzhen Chipscreen Biosciences Co., Ltd. 187.43 Million CNY 40.35%
Guizhou Yibai Pharmaceutical Co., Ltd. 355.07 Million CNY 68.511%
Zhongzhu Healthcare Holding Co.,Ltd -234.13 Million CNY 147.755%
Beijing Tongrentang Co., Ltd 4.09 Billion CNY 97.272%
Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co.,Ltd. 186.48 Million CNY 40.046%
Jianmin Pharmaceutical Group Co.,Ltd. 615.11 Million CNY 81.823%
Tibet Weixinkang Medicine Co., Ltd. 266.6 Million CNY 58.062%
CanSino Biologics Inc. -1.64 Billion CNY 106.79%
Zhejiang Hisun Pharmaceutical Co., Ltd. 1.18 Billion CNY 90.527%
Shanghai Jiaoda Onlly Co.,Ltd 17.57 Million CNY -536.055%
Jiang Zhong Pharmaceutical Co.,Ltd 1.03 Billion CNY 89.147%
Mayinglong Pharmaceutical Group Co., LTD. 633.25 Million CNY 82.344%
Cisen Pharmaceutical Co., Ltd. 840.03 Million CNY 86.69%
Zhejiang Cheng Yi Pharmaceutical Co., Ltd. 267.44 Million CNY 58.194%
Hunan Warrant Pharmaceutical Co.,Ltd 292.03 Million CNY 61.715%
Shanghai Fosun Pharmaceutical (Group) Co., Ltd. 5.55 Billion CNY 97.989%
Hunan Fangsheng Pharmaceutical Co., Ltd. 310.08 Million CNY 63.943%
Shaanxi Kanghui Pharmaceutical Co., Ltd. 3.22 Million CNY -3361.757%
Nanjing King-Friend Biochemical Pharmaceutical Co., Ltd -57.84 Million CNY 293.292%
Beijing Sun-Novo Pharmaceutical Research Co., Ltd. 250.5 Million CNY 55.367%
Shanghai Shyndec Pharmaceutical Co., Ltd. 1.97 Billion CNY 94.348%
Shanghai Yizhong Pharmaceutical Co., Ltd. 195.4 Million CNY 42.78%
Tibet Rhodiola Pharmaceutical Holding Co. 976.16 Million CNY 88.546%
Sichuan Huiyu Pharmaceutical Co., Ltd. 203.49 Million CNY 45.056%
Jiangsu Lianhuan Pharmaceutical Co., Ltd. 259.87 Million CNY 56.977%